首页> 外文期刊>Prion >Fibril fragmentation in amyloid assembly and cytotoxicity When size matters
【24h】

Fibril fragmentation in amyloid assembly and cytotoxicity When size matters

机译:淀粉样蛋白组装中的原纤维断裂和细胞毒性

获取原文
           

摘要

Amyloid assemblies are associated with several debilitating human disorders. Understanding the intra- and extracellular assembly of normally soluble proteins and peptides into amyloid aggregates and how they disrupt normal cellular functions is therefore of paramount importance. In a recent report, we demonstrated a striking relationship between reduced fibril length caused by fibril fragmentation and enhanced ability of fibril samples to disrupt membranes and to reduce cell viability. These findings have important implications for our understanding of amyloid disease in that changes in the physical dimensions of fibrils, without parallel changes in their composition or molecular architecture, could be sufficient to alter the biological responses to their presence. These conclusions provide a new hypothesis that the physical dimensions and surface interactions of fibrils play key roles in amyloid disease. Controlling fibril length and stability toward fracturing, and thereby the biological availability of fibril material, may provide a new target for future therapeutic strategies towards combating amyloid disease.
机译:淀粉样蛋白组装体与几种使人衰弱的疾病有关。因此,了解正常可溶的蛋白质和肽在细胞内和细胞外组装成淀粉样聚集体以及它们如何破坏正常的细胞功能至关重要。在最近的报告中,我们证明了由原纤维断裂引起的原纤维长度减少与原纤维样品破坏膜并降低细胞活力的能力增强之间存在惊人的关系。这些发现对我们对淀粉样蛋白疾病的理解具有重要意义,因为原纤维的物理尺寸发生变化,而其组成或分子结构没有平行变化,可能足以改变其存在的生物学反应。这些结论提供了一个新的假设,即原纤维的物理尺寸和表面相互作用在淀粉样蛋白疾病中起关键作用。控制原纤维的长度和对破裂的稳定性,从而控制原纤维材料的生物利用度,可以为对抗淀粉样变性疾病的未来治疗策略提供新的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号